Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 8;12(3):658.
doi: 10.3390/diagnostics12030658.

The Non-Activated Thromboelastometry (NATEM) Assay's Application among Adults and Neonatal/Pediatric Population: A Systematic Review

Affiliations
Review

The Non-Activated Thromboelastometry (NATEM) Assay's Application among Adults and Neonatal/Pediatric Population: A Systematic Review

Petroula Georgiadou et al. Diagnostics (Basel). .

Abstract

The non-activated thromboelastometry (NATEM) assay is a point-of-care assay that can provide a comprehensive insight into the actual hemostatic mechanism. However, there are very limited data about its use in clinical practice. The aim of this study was to systematically review the literature for any data regarding the use of NATEM in several clinical settings. A systematic review of PubMed and Scopus databases was conducted through 20 January 2022 for studies evaluating the use of the NATEM assay in different clinical settings. The literature search yielded a total of 47 publications, 30 of which met the eligibility criteria for this review. Evaluation of NATEM's detecting ability for hemostasis disorders is limited in the literature. The results of the included studies indicate that NATEM seems to be a sensitive method for the detection of hyperfibrinolysis and may have an advantage in the diagnosis of hemostatic disorders. It could be more informative than the other ROTEM assays for detecting changes in coagulation parameters in patients who receive anticoagulants. However, the reported outcomes are highly varying among the included studies. NATEM has a high sensitivity to detect hypo- or hypercoagulability and provides a detailed insight into the whole hemostatic process from clot formation to clot breakdown. It could be a useful technique in variable fields of medicine, not only in adults, but also in pediatric and neonatal populations, to guide different hemostatic treatments and predict coagulation disorders or mortality/morbidity; this issue remains to be further investigated.

Keywords: NATEM; ROTEM; hemostasis; neonates; non-activated thromboelastometry; thromboelastometry.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of the literature review process.

Similar articles

Cited by

References

    1. Honickel M., Grottke O. Rotational thromboelastometry for the diagnosis of coagulation disorders. Med. Klin. Intensivmed. Und Notf. 2018;113:542–551. doi: 10.1007/s00063-016-0194-4. - DOI - PubMed
    1. Bugaev N., Como J.J., Golani G., Freeman J.J., Sawhney J.S., Vatsaas C.J., Yorkgitis B.K., Kreiner L.A., Garcia N.M., Aziz H.A., et al. Thromboelastography and rotational thromboelastometry in bleeding patients with coagulopathy: Practice management guideline from the Eastern Association for the Surgery of Trauma. J. Trauma Acute Care Surg. 2020;89:999–1017. doi: 10.1097/TA.0000000000002944. - DOI - PubMed
    1. Da Luz L.T., Nascimento B., Shankarakutty A.K., Rizoli S., Adhikari N.K. Effect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: Descriptive systematic review. Crit. Care. 2014;18:518. doi: 10.1186/s13054-014-0518-9. - DOI - PMC - PubMed
    1. Görlinger K., Dirkmann D., Hanke A.A. Rotational Thromboelastometry (ROTEM®) In: Gonzalez E., Moore H.B., Moore E.E., editors. Trauma Induced Coagulopathy. Springer International Publishing; Cham, Switzerland: 2016. pp. 267–298. - DOI
    1. Simurda T., Asselta R., Zolkova J., Brunclikova M., Dobrotova M., Kolkova Z., Loderer D., Skornova I., Hudecek J., Lasabova Z., et al. Congenital Afibrinogenemia and Hypofibrinogenemia: Laboratory and Genetic Testing in Rare Bleeding Disorders with Life-Threatening Clinical Manifestations and Challenging Management. Diagnostics. 2021;11:2140. doi: 10.3390/diagnostics11112140. - DOI - PMC - PubMed

LinkOut - more resources